An Interpretation of CSCO/ASCO International Guideline of Chemotherapy in Combination with Radiotherapy for Definitive-intent Treatment of Stage Ⅱ-Ⅳa Nasopharyngeal Carcinoma in 2021

Zhongliu Fangzhi Yanjiu

MOU Yanhua¹  HU Desheng¹  ZHOU Yajuan¹ 

[1] Department of Radiotherapy, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, China;

关键词: nasopharyngeal carcinoma;    radiotherapy;    concurrent chemoradiotherapy;    induction chemotherapy;    guideline;   

DOI  :  10.3971/j.issn.1000-8578.2021.21.0163

来源: DOAJ

【 摘 要 】

Radiotherapy combined with chemotherapy is the main treatment for stage Ⅱ-Ⅳa nasopharyngeal carcinoma (NPC). In the era of intensity-modulated radiation therapy, the timing and implementation of chemotherapy are still controversial. In the past, the clinical guidelines for NPC generally described the specific radiotherapy technology, dose fractionation and the specific scheme of combined application of radiotherapy and chemotherapy, and may lack specific practical guidance. The joint international guidelines for NPC by CSCO and ASCO elaborates the mode and specific implementation recommendations of radical chemoradiotherapy for stage Ⅱ-Ⅳa NPC. This article aims to interpret the specific details of the guideline.

【 授权许可】

Unknown